CAH

Cardinal Health, Inc. 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended December 31, 1998 (the second quarter of fiscal year 1999) and the six months ended December 31, 1998. Cardinal Health, Inc. operates primarily in the wholesale distribution of pharmaceuticals and healthcare services. The financial statements have been restated to reflect the pooling of interests mergers with MediQual Systems, Inc. (February 1998) and R.P. Scherer Corporation (August 1998). A three-for-two stock split was effected in October 1998, and all share data has been retroactively adjusted.

Key Financial Metrics

Note: Revenue includes "Bulk deliveries to customer warehouses" which are recorded at cost with no margin impact.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 26% for the six months ended December 31, 1998, compared to the prior year. Operating revenue grew 26%, driven by a 28% increase in Distribution businesses and an 18% increase in Service businesses.
• Profitability: Net earnings rose 5% to $157.5 million for the six-month period. However, gross margin percentages declined (from 9.15% to 8.62% for the six months) due to a higher mix of lower-margin distribution business and competitive pricing pressures.
• Merger Costs: Merger-related costs significantly impacted earnings, totaling $37.5 million for the six months ended December 31, 1998, compared to $5.4 million in the prior year. This included $12.5 million in restructuring and asset impairment costs related to the Scherer merger.
• Cash Flow: Net cash used in operating activities was $298.2 million for the six months, primarily due to a $476.6 million increase in merchandise inventories and a $116.1 million increase in trade receivables, offset by a $200.1 million increase in accounts payable.

Guidance, Outlook, and Risks

• Allegiance Merger: The Company completed a merger with Allegiance Corporation on February 3, 1999. This transaction involved issuing approximately 70.7 million shares and assuming approximately $892.1 million in long-term debt. Additional merger-related charges are expected in the third quarter of fiscal 1999.
• Future Merger Costs: Management estimates an additional $29.2 million in merger-related costs (net of tax) will be incurred in future periods to integrate Scherer and other acquisitions.
• Year 2000 Compliance: The Company estimates total Year 2000 project costs at approximately $24 million. It expects to complete remediation and testing by June 30, 1999, and does not anticipate a material adverse effect on operations, though risks regarding third-party dependencies remain.
• Legal Proceedings: The Company was a defendant in a consolidated class action lawsuit regarding chargeback pricing; judgment was granted in the Company's favor in November 1998, though plaintiffs have appealed. A civil complaint regarding the Controlled Substance Abuse Act was settled for $487,500 in December 1998.
• Liquidity: The Company issued $150 million in 6.25% Notes due 2008 in July 1998 and maintains a shelf registration for an additional $250 million in debt securities.

Investor Verification Checklist

• Verify the impact of the Allegiance merger on future debt service obligations ($892.1 million assumed) and dilution (70.7 million shares issued).
• Monitor the timing and magnitude of remaining merger-related integration costs, estimated at $29.2 million net of tax.
• Assess the sustainability of gross margin compression in the Distribution segment amidst competitive pricing and high-volume customer mix.
• Review the status of the appealed class action lawsuit regarding chargeback pricing and potential exposure beyond the $1 million cap.
• Confirm the progress of Year 2000 remediation and the adequacy of contingency plans for third-party system failures.